HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multimodal treatment of abdominal and pelvic desmoplastic small round cell tumor with relative good prognosis.

AbstractOBJECTIVE:
To investigate the clinicopathologic features and survival outcomes of desmoplastic small round cell tumor (DSCRT).
METHODS:
The retrospective cohort study was performed on clinical and pathological data of 18 DSCRT patients. Among them, two subgroups were classified according to treatment modalities. 10 cases underwent operation and adjuvant chemotherapy (group 1, 10/18, 55.6%) and 8 cases were diagnosed by fine needle aspiration biopsy without surgical intervention (group 2, 8/18, 44.4%). All cases received six courses of multiple agents chemotherapy.
RESULTS:
All cases were histologically confirmed as DSRCT and Cox regression revealed that sex, tumor localization and treatment modality affected patient outcomes. Kaplan-Meier analysis revealed that the median survival time was 22.0 ± 4.0 mo in group 1 versus 9.0 ± 0.7 mo in group 2.
CONCLUSION:
DSRCT is highly aggressive malignance with poor prognosis, surgical excision with combination of chemotherapy can significantly improve the survival outcomes.
AuthorsYuhong Tang, Hualin Song, Yali Bao, Yang Zhi
JournalInternational journal of surgery (London, England) (Int J Surg) Vol. 16 Issue Pt A Pg. 49-54 (Apr 2015) ISSN: 1743-9159 [Electronic] England
PMID25743388 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
Topics
  • Abdominal Neoplasms (diagnosis, mortality, therapy)
  • Adolescent
  • Adult
  • Child
  • China (epidemiology)
  • Combined Modality Therapy
  • Desmoplastic Small Round Cell Tumor (diagnosis, mortality, therapy)
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Pelvic Neoplasms (diagnosis, mortality, therapy)
  • Prognosis
  • Retrospective Studies
  • Survival Rate (trends)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: